Abiomed Inc (ABMD)
$265.25 2.96 (1.10%)
16:43 EST ABMD Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 11.80B
PE Ratio 108.27
Volume (Avg. Vol.) 169,002
Day's Range 263.76 - 268.22
52-Week Range 119.01 - 319.19
Dividend & Yield N/A (N/A)
ABMD Stock Predictions, Articles, and Abiomed Inc News
- From InvestorPlace
- From the Web
Each case for these momentum stocks is backed by Wall Street's top analysts and the stocks should continue to power through 2018 and beyond.
Niche medical device maker Abiomed has plenty of heart for growth. ABMD stock isn't the sexiest play, but it's well worth a look.
Abiomed stock is down 10 percent following first-quarter earnings. The company exceeded expectations and reported growth in the triple digits. So what gives? The good news is priced in.
If you're looking for some stellar stocks to buy, these 7 A-rated stocks are worth a look from any investor.
Bitcoin may look attractive, but there are stocks to buy with growth potential that you don't have to worry about going broke to own.
These are the best stocks to buy before the start of the new year. Here's what investors need to know about each stock.
As one of the 785 companies in the GICS Health Care sector Abiomed Inc (NASDAQ:ABMD) is a constituent of the 164 company Health Care Equipment & Supplies GICS industry group within this sector. ABMD has a market value of $8.6 billion which is in the top quarter of its industry group. The stock's current Portfolio Grader score places it 1 among the 164 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 1 among the 785 companies in the sector, and number 5 in the nearly 5,000 company Portfolio Grader universe.
This week, 3 Health Care Equipment & Supplies stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
The grades of 5 Health Care Equipment & Supplies stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Don't be scared off by Abiomed's competition. ABMD is in a great position: It's on an upward trajectory and it has a lot of buyout potential.
Ruby Tuesday (RT) missed quarterly earnings expectations, Gap (GPS) sales continued their downward trend and Abiomed (ABMD) got good news from the FDA.
Medical device maker ABIOMED continues to grow top and bottom line results, and is a strong buy in an industry on the rise
The next breakthrough in medical device technology may save lives and make investors money. Here are 4 medical instrument maker stocks to buy
Exchange-traded funds (ETFs) are simply booming. These 5 ETFs soared in 2015, and could easily carry over as big winners into the new year
Healthcare stocks declined on Wall Street on Tuesday, down 2.4%.
This week, these five stocks have the best ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
This week, these five stocks have the best ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.
Healthcare stocks rose 2.1% on Wall Street on Wednesday.
It's the job of analysts to keep earnings and revenues growth figures up to date, and here are 5 stocks that have analysts buzzing
Navellier RatingsPowered by Portfolio Grader